Introduction Executive Summary Behçet’s syndrome: Overview • Causes • Mechanism of Action • Signs and Symptoms • Diagnosis • Disease Management Pipeline Therapeutics • Comparative Analysis Therapeutic Assessment • Assessment by Product Type • Assessment by Stage and Product Type • Assessment by Route of Administration • Assessment by Stage and Route of Administration • Assessment by Molecule Type • Assessment by Stage and Molecule Type Behçet’s syndrome – DelveInsight’s Analytical Perspectives Mid Stage Products (Phase II) • Comparative Analysis Hemay005: Tianjin Hemay Pharmaceutical • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Early Stage Products (Phase I) • Comparative Analysis Drug name: Company name • Product Description • Research and Development • Product Development Activities Drug profiles in the detailed report….. Inactive Products • Comparative Analysis Behçet’s syndrome Key Companies Behçet’s syndrome Key Products Behçet’s syndrome- Unmet Needs Behçet’s syndrome- Market Drivers and Barriers Behçet’s syndrome- Future Perspectives and Conclusion Behçet’s syndrome Analyst Views Behçet’s syndrome Key Companies Appendix

Table 1 Total Products for Behçet’s syndrome Table 2 Late Stage Products Table 3 Mid Stage Products Table 4 Early Stage Products Table 5 Pre-clinical & Discovery Stage Products Table 6 Assessment by Product Type Table 7 Assessment by Stage and Product Type Table 8 Assessment by Route of Administration Table 9 Assessment by Stage and Route of Administration Table 10 Assessment by Molecule Type Table 11 Assessment by Stage and Molecule Type Table 12 Inactive Products

• Tianjin Hemay Pharmaceutical • Actelion Pharmaceuticals • Novartis • Silk Road Therapies, Inc.